CD209 and neoplasm: Engagement of DC-SIGN by tumor-derived ligands suppresses DC maturation by reducing co-stimulatory molecule expression (e.g., CD80, CD86) and limiting pro-inflammatory cytokine production, thereby weakening the initiation of effective T-cell responses.